Applied DNA Sciences Inc (APDN)

Sector:
INFORMATION TECHNOLOGY
Industry:
ELECTRONIC EQUIPMENT
SIC:
SERVICES-MISCELLANEOUS BUSINESS SERVICES
CEO:
James A. Hayward
Employees:
100
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY 11790
631-240-8800

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts.

Data derived from most recent annual or quarterly report
Market Cap 27.699 Million Shares Outstanding7.486 Million Avg 30-day Volume 20.03 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-1.31
Price to Revenue1.1493 Debt to Equity0.0 EBITDA-12.865 Million
Price to Book Value2.2623 Operating Margin-96.00840000000001 Enterprise Value10.787 Million
Current Ratio3.07 EPS Growth0.065 Quick Ratio2.505
1 Yr BETA 0.3461 52-week High/Low 7.35 / 0.62 Profit Margin-95.8943
Operating Cash Flow Growth26.025 Altman Z-Score-29.2655 Free Cash Flow to Firm -6.556 Million
View SEC Filings from APDN instead.

View recent insider trading info

Funds Holding APDN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding APDN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-08-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-09:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-02:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-28:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-07-27:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-23:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-09-17:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SHAMASH YACOV A

    • Director
    31,834 2021-11-01 1

    CATELL ROBERT B

    • Director
    29,845 2021-11-01 1

    HAYWARD JAMES A CHAIRMAN, CEO AND PRESIDENT

    • Officer
    • Director
    219,167 2021-11-01 1

    SIMON SANFORD R

    • Director
    30,094 2021-11-01 1

    MURRAH JUDITH CIO AND COO

    • Officer
    52,127 2021-11-01 1

    BITZER JOHN III

    • Director
    31,586 2021-11-01 1

    CECCOLI JOSEPH D.

    • Director
    30,840 2021-11-01 1

    JANTZEN BETH CHIEF FINANCIAL OFFICER

    • Officer
    45,129 2021-11-01 1

    ANCHIN SCOTT L

    • Director
    29,845 2021-11-01 1

    FERGUSON ELIZABETH M.

    • Director
    29,845 2021-11-01 1

    SHORROCK CLAY CHIEF LEGAL OFFICER

    • Officer
    45,129 2021-11-01 1

    MONTGOMERY WILLIAM W

    • EX 5% OWNER
    No longer subject to file 2020-06-26 0

    RYAN CHARLES S.

    • Director
    0 2019-05-17 0

    LIANG MING-HWA BENJAMIN SECRETARY AND CSO

    • Officer
    0 2016-12-20 0

    GRAY KAROL CHIEF FINANCIAL OFFICER

    • Officer
    0 2014-12-22 0

    SHAMASH YACOV

    • Director
    0 2006-03-17 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    APPLIED DNA SCIENCES INC APDN 2022-08-15 19:45:04 UTC -201.2809 203.6009 45000
    APPLIED DNA SCIENCES INC APDN 2022-08-15 19:15:04 UTC -201.2809 203.6009 45000
    APPLIED DNA SCIENCES INC APDN 2022-08-15 18:45:04 UTC -204.6528 206.9728 45000
    APPLIED DNA SCIENCES INC APDN 2022-08-15 18:15:04 UTC -204.6528 206.9728 45000
    APPLIED DNA SCIENCES INC APDN 2022-08-15 17:45:04 UTC -204.6528 206.9728 45000
    APPLIED DNA SCIENCES INC APDN 2022-08-15 17:15:03 UTC -204.6528 206.9728 45000
    APPLIED DNA SCIENCES INC APDN 2022-08-15 16:45:04 UTC -204.0721 206.3921 45000
    APPLIED DNA SCIENCES INC APDN 2022-08-15 16:15:04 UTC -204.0721 206.3921 50000
    APPLIED DNA SCIENCES INC APDN 2022-08-15 15:45:04 UTC -204.0721 206.3921 50000
    APPLIED DNA SCIENCES INC APDN 2022-08-15 15:15:04 UTC -204.0721 206.3921 40000
    APPLIED DNA SCIENCES INC APDN 2022-08-15 14:45:04 UTC -204.0721 206.3921 45000
    APPLIED DNA SCIENCES INC APDN 2022-08-15 14:15:03 UTC -204.0721 206.3921 45000
    APPLIED DNA SCIENCES INC APDN 2022-08-15 13:45:04 UTC -236.5463 238.8663 4000
    APPLIED DNA SCIENCES INC APDN 2022-08-15 13:15:04 UTC -236.5463 238.8663 5000
    APPLIED DNA SCIENCES INC APDN 2022-08-15 12:45:04 UTC -236.5463 238.8663 35000
    APPLIED DNA SCIENCES INC APDN 2022-08-12 22:15:03 UTC -236.5463 238.8663 7000
    APPLIED DNA SCIENCES INC APDN 2022-08-12 21:45:04 UTC -240.035 242.355 7000
    APPLIED DNA SCIENCES INC APDN 2022-08-12 21:15:04 UTC -240.035 242.355 7000
    APPLIED DNA SCIENCES INC APDN 2022-08-12 15:45:04 UTC -311.0136 313.3336 30000
    APPLIED DNA SCIENCES INC APDN 2022-08-12 15:15:05 UTC -311.0136 313.3336 40000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments